Behavioral Intervention for Reducing Sedentary Lifestyle in Prostate Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help prostate cancer survivors reduce their sitting time. Participants will be divided into two groups: one will receive a FitBit and support sessions with a movement specialist, while the other will receive only a FitBit and some public health resources. The researchers aim to determine if the support sessions help participants sit less and remain active over time. Ideal candidates are prostate cancer survivors not currently undergoing treatment and who sit for more than 8 hours a day. As an unphased trial, this study allows participants to contribute to innovative research focused on improving long-term health and activity levels.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, since medical clearance from a primary health care provider is required, it's best to discuss your medications with them.
What prior data suggests that this behavioral intervention is safe for prostate cancer survivors?
Research shows that behavioral programs, like the one in this trial, are usually safe and manageable. Participants in similar studies often experience benefits such as reduced stress and improved mental health, with few serious side effects. For instance, mindfulness programs, which resemble this one, have helped reduce stress and anxiety in cancer survivors. Participants typically complete these programs without major issues.
In this trial, participants will use a FitBit and attend sessions with a movement expert. FitBits are commonly used and safe, and tracking daily activity with these devices usually doesn't cause problems. The sessions aim to be encouraging and helpful, enhancing well-being without any risk.
Overall, based on current research and the nature of this program, it is expected to be safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a unique approach to reducing sedentary lifestyles in prostate cancer survivors. Unlike traditional exercise recommendations, this trial combines wearable technology with personalized support. Participants use a FitBit Inspire 2 to track their activity and have access to a movement specialist for one-on-one sessions and group webinars. This method goes beyond just providing information, offering personalized behavioral support to help participants integrate more movement into their daily lives, which could lead to better long-term health outcomes.
What evidence suggests that this behavioral intervention is effective for reducing sedentary lifestyle in prostate cancer survivors?
Research has shown that certain activities can help cancer survivors sit less and be more active. In this trial, participants in the "Intervention" arm will use a FitBit with guidance from a movement expert, an approach proven to increase activity levels and reduce sitting time. This method often enhances physical abilities, mental well-being, and overall quality of life. Meanwhile, participants in the "Fitbit Only" arm will use a FitBit and access publicly available resources about active living. Studies suggest these activities can boost motivation to stay active and enhance social support. For prostate cancer survivors, these changes can lead to better health and a more active lifestyle.13678
Who Is on the Research Team?
Linda Trinh, PhD
Principal Investigator
University of Toronto
Are You a Good Fit for This Trial?
This trial is for prostate cancer survivors in Canada who are mostly inactive, sitting for over 8 hours a day, and not currently undergoing radiation or chemotherapy. They should be ready to start becoming more active, have no severe heart issues or walking disabilities, and must not have had a serious fall recently.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 12-week behavioural intervention including a FitBit and 6 behavioural support sessions with a movement specialist
Follow-up
Participants are monitored for changes in sedentary behaviour and physical activity at 6-months post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- FitBit Only
- Intervention
Trial Overview
The study tests if a 12-week program with a FitBit and behavioral support sessions can reduce sedentary behavior in prostate cancer survivors compared to those just given a FitBit. It also looks at the program's impact on physical activity levels, motivation, sleep quality, social support, physical function, life quality, fatigue disability and mental health.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will be provided with a FitBit Inspire 2 and assigned a movement specialist. They will be asked to monitor their daily steps over the 12-week intervention period. Participants will attend 6 remotely-delivered behaviour change sessions (4 one-on-one sessions with their movement specialist, 2 group-based webinars). Sessions will be delivered bi-weekly and last \~30 minutes.
Participants will be provided with a FitBit Inspire 2 and access to publicly available resources about active living (e.g., 24-hour movement guidelines).
Intervention is already approved in United States for the following indications:
- Loneliness in Older Adults
- Social Isolation
- Emotional Well-being
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Toronto
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
Published Research Related to This Trial
Citations
Behavioral Intervention for Reducing Sedentary Lifestyle in ...
The Digital Meditation Intervention is unique because it uses a remote app to deliver mindfulness meditation training, which can be more accessible and ...
Effectiveness of Web-Based Mindfulness ...
App- and website-based MBIs show promise for improving mental health and QOL outcomes in patients with cancer, and further research is needed.
Efficacy of an online mindfulness program (MindOnLine) to ...
This study reports on the efficacy of MindOnLine, an online mindfulness program, for people living with–and beyond–breast, prostate or colorectal cancer, in ...
Benefits of Remote-Based Mindfulness on Physical Symptom ...
After remote-based mindfulness treatment, cancer survivors showed a significant reduction in fatigue (SMD −0.94; 95% CI: −1.56 to −0.33; P=.002) ...
Mindfulness-Based Cognitive Therapy in Advanced ...
We undertook a randomized controlled trial to assess the effectiveness of MBCT in reducing psychological distress in men with advanced PC. MBCT ...
Changes in Stress Reduction Following a 28-Day Prostate ...
This study presents a secondary analysis of a Phase 2 feasibility study that evaluated the effects of a 28-day PC-PEP intervention on stress reduction.
Mobile Mindfulness Meditation Intervention to Improve the ...
Evaluate the impact and satisfaction of Mobile Mindfulness Meditation on anxiety, pain, fatigue, trauma, and sleep in cancer survivors. Detailed Description.
Mindfulness-Based Stress Reduction for Men on Active ...
Mindfulness-based stress reduction (MBSR) is a structured, 8-week training program that has been shown to reduce symptoms of stress, anxiety, depression and ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.